NYU Langone Medical Center
out of 16
Post on 12-Nov-2014
Embed Size (px)
DESCRIPTIONNYU Langone Medical Center*References*Blackburn G. Effect of degree of weight loss on health benefit...
- 1. NYU Langone Medical Center NYU Langone Medical Center * References *Blackburn G. Effect of degree of weight loss on health benefits.Obes Res.1995;3(suppl 2):211S216S. *Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II.Ann Intern Med.2001;134:1-11. *Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study.Ann Intern Med.1992;116:535-539. *Goldstein DJ. Beneficial health effects of modest weight loss.Int J Obes.1992;16:397-415. *Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data.Am J Clin Nutr.1997;66(suppl 4):1044S-1050S. *Moore LL, Visioni AJ, Wilson PW, et al. Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus?Epidemiology.2000;11:269-273. *Kaats GR, Blum K, Fisher JA, et al. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study.Curr Ther Res.1996;57:747765. *Kaats GR, Blum K, Pullin D, et al. A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study.Curr Ther Res.1998;59:379-388. *Grant KE, Chandler RM, Castle AL, et al. Chromium and exercise training: Effect on obese women.Med Sci Sports Exerc.1997;29:992-998. *Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition.J Sports Med Phys Fitness.1995;35:273-280. *Clancy SP, Clarkson PM, DeCheke ME, et al. Effects of chromium picolinate supplementation on body composition, strength, and urinary chromium loss in football players.Int J Sport Nutr.1994;4:142-153. *Hallmark MA, Reynolds TH, DeSouza CA, et al. Effects of chromium and resistive training on muscle strength and body composition.Med Sci Sports Exerc.1996;28:139-144. *Amato P, Morales AJ, Yen SS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women.J Gerontol A Biol Sci Med Sci.2000;55:M260-M263. *Lukaski HC, Bolonchuk WW, Siders WA, et al. Chromium supplementation and resistance training:
- 2. effects on body composition, strength, and trace element status of men.Am J Clin Nutr.1996;63:954964. *Stanko RT, Reynolds HR, Hoyson R, et al. Pyruvate supplementation of a low-cholesterol, low-fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients.Am J Clin Nutr.1994;59:423-427. *Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate.Am J Clin Nutr.1992;56:630-635. *Stanko RT, Arch JE. Inhibition of regain in body weight and fat with addition of 3-carbon compounds to the diet with hyperenergetic refeeding after weight reduction.Int J Obes Relat Metab Disord.1996;20:925-930. *Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate.Am J Clin Nutr.1992;55:771-772. *Kalman D, Colker CM, Wilets I, et al. The effects of pyruvate supplementation on body composition in overweight individuals.Nutrition.1999;15:337-340. *Ryttig KR, Tellnes G, Haegh L, et al. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.Int J Obes.1989;13:165-171. *Rigaud D, Ryttig KR, Angel LA, et al. Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial.Int J Obes.1990;14:763769. *Rossner S, von Zweigbergk D, Ohlin A, et al. Weight reduction with dietary fibre supplements. Results of two double-blind randomized studies.Acta Med Scand.1987;222:83-88. *Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study.Int J Obes.1984;8:289-293. *Reffo GC, Ghirardi PE, Forattani C. Double-blind evaluation of glucomannan versus placebo in postinfarcted patients after cardiac rehabilitation.Curr Ther Res.1990;47:753-758. *Vido L, Facchin P, Antonello I, et al. Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo.Paediatr Paedol.1993;28:133-136. *Schiller RN, Barrager E, Schauss AG, et al. A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals.J Am Nutraceutical Assoc.2001;4:42-49. *Pittler MH, Abbot NC, Harkness EF, et al. Randomized, double-blind trial of chitosan for body weight reduction.Eur J Clin Nutr.1999;53:379-381. *Di Lorenzo C, Williams CM, Hajnal F, et al. Pectin delays gastric emptying and increases satiety in obese subjects.Gastroenterology.1988;95:1211-1215.
- 3. *Wilmshurst P, Crawley JC. The measurement of gastric transit time in obese subjects using 24Na and the effects of energy content and guar gum on gastric emptying and satiety.Br J Nutr.1980;44:16. *Heini AF, Lara-Castro C, Schneider H, et al. Effect of hydrolyzed guar fiber on fasting and postprandial satiety and satiety hormones: a double-blind, placebo-controlled trial during controlled weight loss.Int J Obes.1998;22:906-909. *Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study.Int J Obes.1984;8:289-293. *Reffo GC, Ghirardi PE, Forattani C. Double-blind evaluation of glucomannan versus placebo in postinfarcted patients after cardiac rehabilitation.Curr Res Ther.1990;47:753-758. *Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.Diabetes Care.1999;22:913-919. *Ryttig KR, Tellnes G, Haegh L, et al. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.Int J Obes.1989;13:165-171. *Rossner S, von Zweigbergk D, Ohlin A, et al. Weight reduction with dietary fibre supplements. Results of two double-blind randomized studies.Acta Med Scand.1987;222:83-88. *Byerley WF, Judd LL, Reimherr FW, et al. 5-hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.J Clin Psychopharmacol.1987;7:127-137. *Poldinger W, Calanchini B, Schwarz W. A functional-dimensional approach to depression: Serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.Psychopathology.1991;24:53-81. *Ceci F, Cangiano C, Cairella M, et al. The effects of 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects.J Neural Transm.1989;76:109-117. *Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan.Am J Clin Nutr.1992;56:863-867. *Cangiano C, Ceci F, Cairella M, et al. Effects of 5-Hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects.Adv Exp Med Biol.1991;294:591-593. *Cangiano C, Laviano A, Del Ben M, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients.Int J Obes Relat Metab Disord.1998;22:648-654. *Chao D, Espeland MA, Farmer D, et al. Effect of voluntary weight loss on bone mineral density in older overweight women.J Am Geriatr Soc.2000;48:753-759. *Davies KM, Heaney RP, Recker RR, et al. Calcium intake and body weight.J Clin Endocrinol Metab.2000;85:4635-4638.
- 4. *Greenwood MRC, Cleary MP, Gruen R, et al. Effect of hydroxycitrate on development of obesity in the Zucker obese rat.Am J Physiol.1981;240:E72-E78. *Sullivan AC, Triscari J. Metabolic regulation as a control for lipid disorders. Influence ofhydroxycitrate on experimentally induced obesity in the rodent.Am J Clin Nutr.1977;30:767-776. *Sullivan AC, Triscari J, Hamilton JG, et al. Effect ofhydroxycitrate upon the accumulation of lipid in the rat: I. Lipogenesis.Lipids.1974;9:121-128. *Sullivan AC, Triscari J, Hamilton JG, et al. Effect ofhydroxycitrate upon the accumulation of lipid in the rat. II. Appetite.Lipids.1974;9:129-134. *Sergio W. A natural food, malabar tamarind, may be effective in the treatment of obesity.Med Hypotheses.1988;27:39-40. *Lowenstein JM. Effect of hydroxycitrate on fatty acid synthesis by rat liver in vivo.J Biol Chem.1971;246:629-632. *Triscari J, Sullivan AC. Comparative effects of hydroxycitrate and (+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in vivo.Lipids.1977;12:357-363. *Cheema-Dhadli S, Harlperin ML, Leznoff CC. Inhibition of enzymes which interact with citrate by hydroxycitrate and 1,2,3,-tricarboxybenzene.Eur J Biochem.1973;38:98-102. *Sullivan AC, Hamilton JG, Miller ON, et al. Inhibition of lipogenesis in rat liver byhydroxycitrate.Arch Biochem Biophys.1972;150:183-190. *Heymsfield SB, Allison DB, Vasselli JR, et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.JAMA.1998;280:1596-1600. *Kriketos AD, Thompson HR, Greene H, et al. Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state.Int J Obes Relat Metab Disord.1999;23:867-873. *Mattes RD, Bormann L. Effects of hydroxycitric acid on appetitive variables.Physiol Behav.2000;71:87-94. *Astrup A, Breum L, Toubro S, et al. The effect a
View more >
Department of Radiology - NYU School of - NYU Langone nbsp;· NYU Department of Radiology. NYU Langone Medical Center New York, NY OCT 22–26 Fall Radiology Symposium The Roosevelt Hotel Sponsored by the
SURGICAL EMERGENCIES IN THE NEWBORN TRACY L. MCTIERNAN, MA, CPNP DIVISION OF PEDIATRIC SURGERY NYU LANGONE MEDICAL CENTER
INTERVIEW EDITION - NYU Langone Health ?· INTERVIEW EDITION Welcome to Sackler! ... Vanderbilt University…
Tumor Lysis Syndrome - NYU Langone Health ?· Background Tumor lysis syndrome (TLS) was first described…
Prevention Research Center - NYU Langone Health ?· CEED/PRC Staff; 5) Conference Morning ... Prevention…
GRAND ROUNDS - NYU Langone Health ?· impaired cyclic AMP generation and phos ... Hypomagnesemia results…
Case study New York University Langone Medical ?· Case study New York University Langone Medical Center…
Hospital-Acquired VTE: What We Have Learned Martha J. Radford, MD Chief Quality Officer NYU Langone Medical Center September 2009
NYU Langone Medical Center Momentum ?· puzzle at Tisch was the engagement of ... developing world.”…
Department of Orthopaedic Surgery - NYU Langone Health ?· 2 Department of Orthopaedic Surgery Introduction…
Truncus Arteriosus - Interrupted Aortic Arch Surgical Repair Ralph S. Mosca, M.D. NYU Langone Medical Center New York